SCHEMBL9998592

SCHEMBL9998592

C=C(COC(C)=O)Cc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
PAM P19021 1/20 0.49
MAPK1 P28482 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
AKR1B1 P15121 1/20 0.45
TSHR P16473 1/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
GLS O94925 1/20 0.41
MEN1 O00255 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27733958 0.86 PAM (0.46) ALDH1A1PAMMAPK1L3MBTL1CES2
SCHEMBL2254547 0.81 ALDH1A1 (0.60) ALDH1A1PAMMAPK1L3MBTL1CES2
SCHEMBL9997729 0.81 ALDH1A1 (0.55) ALDH1A1PAMMAPK1L3MBTL1CES2
SCHEMBL9997727 0.81 ALDH1A1 (0.55) ALDH1A1PAMMAPK1L3MBTL1CES2
SCHEMBL4884398 0.80 CNR2 (0.40) ALDH1A1L3MBTL1KMT2ASMN1; SMN2NPC1
SCHEMBL4874815 0.80 SMN1; SMN2 (0.43) ALDH1A1L3MBTL1KMT2ASMN1; SMN2NPC1
SCHEMBL18295996 0.75 ALDH1A1 (0.43) ALDH1A1MAPK1L3MBTL1TSHRSMN1; SMN2
SCHEMBL161364 0.74 ALDH1A1 (0.50) ALDH1A1CES2CES1TSHRSMN1; SMN2
SCHEMBL17928599 0.74 ALDH1A1 (0.63) ALDH1A1PAMMAPK1L3MBTL1CES2
SCHEMBL8046342 0.74 ALDH1A1 (0.50) ALDH1A1PAMMAPK1L3MBTL1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed
US-20080064624-A1 Organoleptic Compounds and Their Use in Perfume Compositions KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2008-03-13 US disclosed
US-20080064624-A1 Organoleptic Compounds and Their Use in Perfume Compositions KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 ALDH1A1 160/4885PAM 1298/4885MAPK1 1707/4885
US-20080064624-A1 Organoleptic Compounds and Their Use in Perfume Compositions CPT1A, CYP2E1, TRPA1 ALDH1A1 378/4885PAM 957/4885MAPK1 4224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.